FKBP25 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-18658
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Clonality
Host
Scientific Data Images for FKBP25 Antibody
Western Blot: FKBP25 Antibody [NBP3-18658]
Western Blot: FKBP25 Antibody [NBP3-18658] - Figure 2. Western blot analysis using the antibody directed against FKBP25 (1) Western blot was performed on whole cell lysates from mouse fibroblasts (NIH3T3) and embryonic stem cells (E14Tg2a) with the antibody against mouse FKBP25 , diluted 1:500 in BSA/ PBS-Tween. The molecular weight marker (in kDa) is shown on the left; the location of the protein of interest (expected size: 25 kDa) is indicated on the right.ELISA: FKBP25 Antibody [NBP3-18658]
ELISA: FKBP25 Antibody [NBP3-18658] - Figure 1. Determination of the titer To determine the titer, an ELISA was performed using a serial dilution of the antibody directed against mouse FKBP25 . The plates were coated with the peptide used for immunization of the rabbit. By plotting the absorbance against the antibody dilution (Figure 1), the titer of the antibody was estimated to be 1:5,400.Applications for FKBP25 Antibody
ELISA
Immunohistochemistry
Immunohistochemistry-Paraffin
Simple Western
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: FKBP25
FK506 binding protein, 25 kDa molecular weight (FKBP25), also called FKBP3, is a peptidyl-prolyl isomerase that catalyzes the transition between cis- and trans-proline residues critical for proper folding of proteins. The macrolide immunosuppressant Rapamycin is a potent inhibitor of FKBP25. FKBP25 is localized in the nucleus, where it alters the activity of histone deacetylases and transcription factors. FKBP25 is found in many tissues, including the brain, thymus, and spleen.
Additional FKBP25 Products
Product Specific Notices for FKBP25 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.